ALUROTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ALURW
ALLURION TECHNOLOGIES, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 15, 2026
$0.47+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $6.34M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.5100 (−76.07%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ALLURION TECHNOLOGIES, INC. saw revenue fall 55.5% to $12.60M over the twelve months to Mar 31, 2026.
Revenue
$12.60M
-55.5% vs. a year earlier
Operating income
-$26.61M
TTM Q1 2026
EPS, diluted
-$3.86
TTM Q1 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $6.34M
- P/E ratio
- –
- Price to sales
- 0.50
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $12.60M
- Net income
- -$33.35M
- EPS, diluted
- -$3.86
- Book value per share
- -$5.84
- Diluted shares
- 13M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$12.60M-55.5% YoY
Gross profit
$6.64M-64.7% YoY
Operating income
-$26.61M
Net income
-$33.35M
EPS, diluted
-$3.86
Free cash flow
–
Reported periodTrailing twelve months